The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

COMPARATIVE RESULTS IN SEIZURE CONTROL USING PHENOBARBITAL, DILANTIN, AND MESANTOIN

Published Online:https://doi.org/10.1176/ajp.107.6.415

Phenobarbital is still the most effective anticonvulsant in treatment of grand mal epilepsy. Phenobarbital, if incompletely effective, when used alone, is still more effective when supplemented with either Dilantin or Mesantoin than any single drug used alone or in other combination. Using a supplemental drug when indicated doubles the number of patients that respond to phenobarbital. Maintaining a reasonable dosage results, in this study, in complete absence of toxic effects from phenobarbital. Mesantoin is twice as effective as Dilantin as an anticonvulsant but is twice as toxic.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.